title: Cutaneous Adverse Reaction to Mogamulizumab May Indicate Favourable Prognosis in Adult T-cell Leukaemia-lymphoma.
authors.affiliation: Department of dermatology, Imamura Bun-in Hospital, 8900064 Kagoshima, Japan. ke.yonekura@jiaikai.jp.
authors.forename: Kentaro
authors.initials: K
authors.lastname: Yonekura
authors.forename: Masahito
authors.initials: M
authors.lastname: Tokunaga
authors.forename: Nobuyo
authors.initials: N
authors.lastname: Kawakami
authors.forename: Koichiro
authors.initials: K
authors.lastname: Takeda
authors.forename: Tamotsu
authors.initials: T
authors.lastname: Kanzaki
authors.forename: Nobuaki
authors.initials: N
authors.lastname: Nakano
authors.forename: Ayumu
authors.initials: A
authors.lastname: Kubota
authors.forename: Shogo
authors.initials: S
authors.lastname: Takeuchi
authors.forename: Yoshifusa
authors.initials: Y
authors.lastname: Takatsuka
authors.forename: Masao
authors.initials: M
authors.lastname: Seto
authors.forename: Atae
authors.initials: A
authors.lastname: Utsunomiya
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects*; D003875:Drug Eruptions / Q000209:etiology* / Q000473:pathology; D005260:Female; D006801:Humans; D015459:Leukemia-Lymphoma, Adult T-Cell / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011379:Prognosis
chemical_list: D061067:Antibodies, Monoclonal, Humanized; C549035:mogamulizumab